Top Institutions in Ophthalmology - Retinal Diseases and Regenerative Medicine
Leading institutions conduct translational and clinical research involving stem cell therapies, retinal cell biology, and advanced surgical implantation techniques for retinal diseases. They lead multi-phase clinical trials evaluating safety and efficacy of regenerative implants for GA and AMD.
-
#1
USC Roski Eye Institute
Los Angeles, CA
Home to the principal investigator of the PATCH AMD trial, USC Roski Eye Institute leads pioneering clinical trials on stem cell–derived RPE implants for geographic atrophy, combining advanced retinal surgery with regenerative therapies.
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
A global leader in retinal disease research and stem cell transplantation, this institution has extensive experience in clinical trials for AMD and regenerative therapies, supported by cutting-edge imaging and molecular biology platforms.
-
#3
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Renowned for clinical excellence and research in retinal degenerations, Bascom Palmer conducts numerous clinical trials on AMD and is advancing regenerative approaches including stem cell and implant technologies.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in retinal disease research and regenerative medicine, with active programs in stem cell biology and clinical trials targeting AMD and geographic atrophy.
-
#5
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
As one of the world’s leading eye hospitals, Moorfields and UCL have pioneered stem cell and gene therapy approaches for retinal diseases, including clinical trials targeting RPE replacement in geographic atrophy.